Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Small molecule modulation of the p75 neurotrophin receptor inhibits multiple amyloid beta-induced tau pathologies
Tao Yang, Kevin Tran, Anne Y. Zeng, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial
Hayley R. C. Shanks, Kewei Chen, Eric M. Reiman, et al.
Nature Medicine (2024) Vol. 30, Iss. 6, pp. 1761-1770
Open Access | Times Cited: 17
The therapeutic landscape of tauopathies: challenges and prospects
Jeffrey L. Cummings, María Isabel González, Martyn C. Pritchard, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 23
Investigating the Impact of Sorghum on Tau Protein Phosphorylation and Mitochondrial Dysfunction Modulation in Alzheimer’s Disease: An In Vitro Study
Nasim Rezaee, Eugene Hone, Hamid R. Sohrabi, et al.
Nutrients (2025) Vol. 17, Iss. 3, pp. 516-516
Open Access | Times Cited: 1
Pharmacological Modulators of Small GTPases of Rho Family in Neurodegenerative Diseases
William Guiler, Addison Koehler, Christi Boykin, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 43
In vivo functions of p75NTR: challenges and opportunities for an emerging therapeutic target
Subash C. Malik, Elif G. Sözmen, Bernat Baeza-Raja, et al.
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 9, pp. 772-788
Open Access | Times Cited: 43
The Nerve Growth Factor Receptor (NGFR/p75NTR): A Major Player in Alzheimer’s Disease
Francesco Bruno, Paolo Abondio, Alberto Montesanto, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3200-3200
Open Access | Times Cited: 18
Fyn Kinase Activity and Its Role in Neurodegenerative Disease Pathology: a Potential Universal Target?
Bianca Guglietti, Srisankavi Sivasankar, Sanam Mustafa, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 11, pp. 5986-6005
Closed Access | Times Cited: 33
Targeting brain‐derived neurotrophic factor in the treatment of neurodegenerative diseases: A review
Dong Wang, Zhi‐Chen Lang, Shi‐Nan Wei, et al.
Neuroprotection/Neuroprotection (Chichester, England. Print) (2024) Vol. 2, Iss. 2, pp. 67-78
Open Access | Times Cited: 6
NGF-based cholinergic therapies in Alzheimer disease
Sumonto Mitra, Ruchi Gera, Maria Eriksdotter
Handbook of clinical neurology (2025), pp. 123-135
Closed Access
Cellular response to β‐amyloid neurotoxicity in Alzheimer's disease and implications in new therapeutics
Haolin Zhang, Xianghua Li, Xiaoli Wang, et al.
Animal Models and Experimental Medicine (2023) Vol. 6, Iss. 1, pp. 3-9
Open Access | Times Cited: 8
Fading memories in aging and neurodegeneration: Is p75 neurotrophin receptor a culprit?
Lik‐Wei Wong, Zijun Wang, Sheila Rui Xia Ang, et al.
Ageing Research Reviews (2022) Vol. 75, pp. 101567-101567
Closed Access | Times Cited: 13
Getting Into the Brain: The Intranasal Approach to Enhance the Delivery of Nerve Growth Factor and Its Painless Derivative in Alzheimer’s Disease and Down Syndrome
Simona Capsoni, Antonino Cattaneo
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 13
P75 neurotrophin receptor as a therapeutic target for drug development to treat neurological diseases
Liu‐Lin Xiong, Li Chen, Isaac Deng, et al.
European Journal of Neuroscience (2022) Vol. 56, Iss. 8, pp. 5299-5318
Closed Access | Times Cited: 13
The role of brain-derived neurotrophic factor and the neurotrophin receptor p75NTR in age-related brain atrophy and the transition to Alzheimer’s disease
Shaun Cade, Xin‐Fu Zhou, Larisa Bobrovskaya
Reviews in the Neurosciences (2022) Vol. 33, Iss. 5, pp. 515-529
Open Access | Times Cited: 11
The Nerve Growth Factor Receptor (NGFR/P75<sup>ntr</sup>): A Major Player in Alzheimer’s Disease
Francesco Bruno, Paolo Abondio, Alberto Montesanto, et al.
(2023)
Open Access | Times Cited: 5
Targeting Endogenous Mechanisms of Brain Resilience for the Treatment and Prevention of Alzheimer’s Disease
Hayley R. C. Shanks, Kate M. Onuska, Stephen M. Massa, et al.
The Journal of Prevention of Alzheimer s Disease (2023)
Open Access | Times Cited: 5
Post-Stroke Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Attenuates Chronic Changes in Brain Metabolism, Increases Neurotransmitter Levels, and Improves Recovery
Thuy‐Vi V. Nguyen, Rachel H. Crumpacker, Kylie Calderon, et al.
Journal of Pharmacology and Experimental Therapeutics (2021) Vol. 380, Iss. 2, pp. 126-141
Open Access | Times Cited: 11
p75NTR upregulation following perinatal hypoxia leads to deficits in parvalbumin-expressing GABAergic cell maturation, cortical activity and cognitive abilities in adult mice
Bidisha Chattopadhyaya, Karen K.Y. Lee, Maria Isabel Carreno-Muñoz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
p75NTR Modulation Reduces Oxidative Stress and the Expression of Pro-Inflammatory Mediators in a Cell Model of Rett Syndrome
Michela Varone, Giuseppe Scavo, Mayra Colardo, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2624-2624
Open Access | Times Cited: 1
Impact of Pharmacological and Non-Pharmacological Modulators on Dendritic Spines Structure and Functions in Brain
Arehally M. Mahalakshmi, Bipul Ray, Sunanda Tuladhar, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3405-3405
Open Access | Times Cited: 9
Effects of central administration of the human Tau proteinon the <i>Bdnf, Trkb, p75, Mapt, Bax</i> and <i>Bcl-2</i> genes expression in the mouse brain
A. S. Oreshko, A. Ya. Rodnyy, Д. В. Базовкина, et al.
Vavilov Journal of Genetics and Breeding (2023) Vol. 27, Iss. 4, pp. 342-348
Open Access | Times Cited: 3
Borolatonin limits cognitive deficit and neuron loss while increasing proBDNF in ovariectomised rats
Mónica Barrón‐González, Astrid M. Rivera‐Antonio, Rosa Adriana Jarillo‐Luna, et al.
Fundamental and Clinical Pharmacology (2024) Vol. 38, Iss. 4, pp. 730-741
Closed Access
Multimodal beneficial effects of BNN27, a Nerve Growth Factor synthetic mimetic, in the 5xFAD mouse model of Alzheimer’s Disease
Ioannis Charalampopoulos, Maria Kokkali, Kanelina Karali, et al.
Research Square (Research Square) (2024)
Open Access
Prefrontal Cortical Projection Neurons: Involvement in Shaping Different Types of Behaviors, BDNF Expression and Transport
U. S. Drozd, Ya. A. Frik, A. V. Smagin, et al.
Journal of Evolutionary Biochemistry and Physiology (2024) Vol. 60, Iss. 5, pp. 2116-2133
Closed Access
Understanding recent advances in non‐amyloid/non‐tau (NANT) biomarkers and therapeutic targets in Alzheimer's disease
Linda J. Van Eldik, Eric Siemers, Emily C. Collins, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2024) Vol. 10, Iss. 4
Open Access
Page 1 - Next Page

Scroll to top